Journal article
The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function
Cell metabolism, Vol.20(1), pp.61-72
07/01/2014
DOI: 10.1016/j.cmet.2014.05.004
PMCID: PMC4079750
PMID: 24930970
Abstract
CD4 T cell activation leads to proliferation and differentiation into effector (Teff) or regulatory (Treg) cells that mediate or control immunity. While each subset prefers distinct glycolytic or oxidative metabolic programs in vitro, requirements and mechanisms that control T cell glucose uptake and metabolism in vivo are uncertain. Despite expression of multiple glucose transporters, Glut1 deficiency selectively impaired metabolism and function of thymocytes and Teff. Resting T cells were normal until activated, when Glut1 deficiency prevented increased glucose uptake and glycolysis, growth, proliferation, and decreased Teff survival and differentiation. Importantly, Glut1 deficiency decreased Teff expansion and the ability to induce inflammatory disease in vivo. Treg cells, in contrast, were enriched in vivo and appeared functionally unaffected and able to suppress Teff, irrespective of Glut1 expression. These data show a selective in vivo requirement for Glut1 in metabolic reprogramming of CD4 T cell activation and Teff expansion and survival.
Details
- Title: Subtitle
- The glucose transporter Glut1 is selectively essential for CD4 T cell activation and effector function
- Creators
- Andrew N Macintyre - Department of Pharmacology and Cancer Biology, Immunology, Sarah W. Stedman Nutrition and Metabolism Center, Duke University, Durham, NC 27710, USAValerie A Gerriets - Department of Pharmacology and Cancer Biology, Immunology, Sarah W. Stedman Nutrition and Metabolism Center, Duke University, Durham, NC 27710, USAAmanda G Nichols - Department of Pharmacology and Cancer Biology, Immunology, Sarah W. Stedman Nutrition and Metabolism Center, Duke University, Durham, NC 27710, USARyan D Michalek - Department of Pharmacology and Cancer Biology, Immunology, Sarah W. Stedman Nutrition and Metabolism Center, Duke University, Durham, NC 27710, USAMichael C Rudolph - Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USADivino Deoliveira - Division of Hematological Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, NC 27710, USASteven M Anderson - Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USAE Dale Abel - Fraternal Order of Eagles Diabetes Research Center, Division of Endocrinology and Metabolism, Department of Medicine, Carver College of Medicine University of Iowa, Iowa City, IA 52242, USABenny J Chen - Division of Hematological Malignancies and Cellular Therapy, Department of Medicine, Duke University, Durham, NC 27710, USALaura P Hale - Department of Pathology, Duke University, Durham, NC 27710, USAJeffrey C Rathmell - Department of Pharmacology and Cancer Biology, Immunology, Sarah W. Stedman Nutrition and Metabolism Center, Duke University, Durham, NC 27710, USA
- Resource Type
- Journal article
- Publication Details
- Cell metabolism, Vol.20(1), pp.61-72
- Publisher
- United States
- DOI
- 10.1016/j.cmet.2014.05.004
- PMID
- 24930970
- PMCID
- PMC4079750
- ISSN
- 1550-4131
- eISSN
- 1932-7420
- Grant note
- U54 HL112311 / NHLBI NIH HHS R01 AI063345 / NIAID NIH HHS U01 HL087947 / NHLBI NIH HHS P01 HD038129 / NICHD NIH HHS T32 HD007186 / NICHD NIH HHS R01CA138482 / NCI NIH HHS R03 AI106835 / NIAID NIH HHS R01AI063345 / NIAID NIH HHS P01CA047741 / NCI NIH HHS R01 HL108006 / NHLBI NIH HHS P30 CA014236 / NCI NIH HHS R56AI102074 / NIAID NIH HHS R01 CA138482 / NCI NIH HHS P01 CA047741 / NCI NIH HHS U01HL087947 / NHLBI NIH HHS R56 AI102074 / NIAID NIH HHS R01HL108006 / NHLBI NIH HHS
- Language
- English
- Date published
- 07/01/2014
- Academic Unit
- Roy J. Carver Department of Biomedical Engineering; Biochemistry and Molecular Biology; Endocrinology and Metabolism; Internal Medicine
- Record Identifier
- 9984024420602771
Metrics
23 Record Views